Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Sep;61(9):1551-7.
doi: 10.1002/pbc.25044. Epub 2014 Apr 7.

Challenges for Children and Adolescents With Cancer in Europe: The SIOP-Europe Agenda

Affiliations
Free PMC article

Challenges for Children and Adolescents With Cancer in Europe: The SIOP-Europe Agenda

Gilles Vassal et al. Pediatr Blood Cancer. .
Free PMC article

Abstract

In Europe, 6,000 young people die of cancer yearly, the commonest disease causing death beyond the age of 1 year. In addition, 300,000-500,000 European citizens are survivors of a childhood cancer and up to 30% of them have severe long-term sequelae of their treatment. Increasing both cure and quality of cure are the two goals of the European paediatric haematology/oncology community. SIOPE coordinates and facilitates research, care and training which are implemented by the 18 European study groups and 23 national paediatric haematology/oncology societies. SIOPE is the European branch of the International Society of Paediatric Oncology and one of the six founding members of the European Cancer Organisation. SIOPE is preparing its strategic agenda to assure long-term sustainability of clinical and translational research in paediatric malignancies over the next 15 years. SIOPE tackles the issues of equal access to standard care and research across Europe and improvement of long term follow up. SIOPE defined a comprehensive syllabus for training European specialists. A strong partnership with parent, patient and survivor organisations is being developed to successfully achieve the goals of this patient-centred agenda. SIOPE is advocating in the field of EU policies, such as the Clinical Trials Regulation and the Paediatric Medicine Regulation, to warrant that the voice of young people is heard and their needs adequately addressed. SIOPE and the European community are entirely committed to the global agenda against childhood cancers to overcome the challenges to increasing both cure and quality of cure of young people with cancer.

Keywords: cancer; care; education; oncopolicy; research.

Figures

Fig 1
Fig 1
Map of paediatric haematology oncology in Europe. The figure shows member states from the European Union (blue) and out of the European Union (pink), as well as member states with (plain colour) or without (dashed) a National Paediatric Haematology Oncology Society.

Similar articles

See all similar articles

Cited by 5 articles

References

    1. Ferlay J, Shin HR, Bray F, et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127:2893–2917. - PubMed
    1. Gatta G, Botta L, Rossi S, et al. Childhood cancer survival in Europe 1999–2007: Results of EUROCARE-5-a population-based study. Lancet Oncol. 2014;15:35–47. - PubMed
    1. Pritchard-Jones K, Pieters R, Reaman GH, et al. Sustaining innovation and improvement in the treatment of childhood cancer: Lessons from high-income countries. Lancet Oncol. 2013;14:e95–e103. - PubMed
    1. Pritchard-Jones K, Kaatsch P, Steliarova-Foucher E, et al. Cancer in children and adolescents in Europe: Developments over 20 years and future challenges. Eur J Cancer. 2006;42:2183–2190. - PubMed
    1. Calaminus G, Birch JR, Hollis R, et al. The role of SIOP as a platform for communication in the global response to childhood cancer. Pediatr Blood Cancer. 2013;60:2080–2086. - PubMed
Feedback